Kineta (STU:J75) Ending Cash Position : €1.70 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kineta Ending Cash Position?

Kineta's Ending Cash Position for the quarter that ended in Mar. 2024 was €1.70 Mil.

Kineta's quarterly Ending Cash Position declined from Sep. 2023 (€7.20 Mil) to Dec. 2023 (€5.37 Mil) and declined from Dec. 2023 (€5.37 Mil) to Mar. 2024 (€1.70 Mil).

Kineta's annual Ending Cash Position increased from Dec. 2021 (€9.93 Mil) to Dec. 2022 (€12.53 Mil) but then declined from Dec. 2022 (€12.53 Mil) to Dec. 2023 (€5.37 Mil).

Kineta Ending Cash Position Historical Data

The historical data trend for Kineta's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Ending Cash Position Chart

Kineta Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

9.49

9.93

12.53

5.37

Kineta Quarterly Data
	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial							8.75	7.29	7.20	5.37	1.70

Kineta Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kineta's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	12.167	+	-6.795
	=	5.37

Kineta's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	5.389	+	-3.689
	=	1.70

Kineta Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kineta's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kineta (STU:J75) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

KA:USA

Address

219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109

Website

https://www.kinetabio.com

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines